Gumapac, Baby Girl .
HRN: 22-87-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
04/18/2023
04/25/2023
IV
15mg
Q24h
Potential Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes